04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
When is it going to return to “normal”? We all have been asking that question. Well, for the const...
Read More >
Recently, the frequency of stockholder demands to inspect corporate books and records pursuant to Se...
Read More >
On February 1, 2021, the U.S. Federal Trade Commission (FTC) issued for publication in the Federal R...
Read More >
Senior Living Provider Rescinded Employment Offer and Refused to Accommodate Applicant With a Disabi...
Read More >
California Gov. Gavin Newsom signed the recently passed Assembly Bill 5 (“AB-5”) codifying the Dyn...
Read More >
North Carolina Attorney General Josh Stein identified opioid abuse and cybersecurity as top challeng...
Read More >